Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Wong, W. Bateman, A. Morris, I. Fraser (1995)
Detection of circulating tumour cells with the magnetic activated cell sorterBritish Journal of Surgery, 82
R. Ghossein, S. Bhattacharya (2000)
Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours.European journal of cancer, 36 13 Spec No
N. Funaki, J. Tanaka, G. Ohshio, H. Onodera, S. Maetani, Masayuki Imamura (1998)
Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients.British Journal of Cancer, 77
R. Rosenberg, A. Hoos, J. Mueller, H. Nekarda (2000)
Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancerBritish Journal of Cancer, 83
SA Burchill, MF Bradbury, K Pittman, J Southgate, B Smith, P Selby (1995)
Detection of epithelial cells in peripheral blood by reverse transcriptase–polymerase chain reaction, 71
Jürgen Weitz, Christian Herfarth (2001)
Surgical strategies and minimal residual disease detection.Seminars in surgical oncology, 20 4
R. Soong, K. Beyser, O. Basten, Andreas Kalbe, J. Rueschoff, K. Tabiti (2001)
Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes.Clinical cancer research : an official journal of the American Association for Cancer Research, 7 11
W. Henke, S. Loening (1998)
Detection of illegitimate transcripts of prostate‐specific antigen mrna in blood by reverse transcription‐polymerase chain reactionInternational Journal of Cancer, 77
J. Lowder, P. Whelton (2003)
Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.Cytotherapy, 5 5
V. Martin, C. Siewert, A. Scharl, T. Harms, R. Heinze, S. Ohl, Andreas Radbruch, S. Miltenyi, J. Schmitz (1998)
Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS.Experimental hematology, 26 3
R. Jung, K. Petersen, W. Krüger, M. Wolf, C. Wagener, A. Zander, M. Neumaier (1999)
Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytesBritish Journal of Cancer, 81
R Rosenberg, A Hoos, J Mueller, P Baier, D Stricker, M Werner, H Nekarda, JR Siewert (2002)
Prognostic significance of cytokeratin‐20 RT‐PCR in lymph nodes of node negative (pN0) colorectal cancer patients, 20
P. Hermanek (1999)
Disseminated tumor cells versus micrometastasis: definitions and problems.Anticancer research, 19 4A
(1998)
Dissemination of tumor cells in patients undergoing surgery for colorectal cancer.
W. Krüger, C. Datta, A. Badbaran, F. Tögel, K. Gutensohn, I. Carrero, N. Kröger, F. Jänicke, A. Zander (2000)
Immunomagnetic tumor cell selection—implications for the detection of disseminated cancer cellsTransfusion, 40
I. Funke, W. Schraut (1998)
Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 2
R. Rosenberg, A. Hoos, James Mueller, P. Baier, D. Stricker, M. Werner, H. Nekarda, J. Siewert (2002)
Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 4
K. Pantel, M. Doeberitz (2000)
Detection and clinical relevance of micrometastatic cancer cellsCurrent Opinion in Oncology, 12
K. Pantel, M. Otte (2001)
Disseminated tumor cells: diagnosis, prognostic relevance, and phenotyping.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 158
E. Borgen, B. Naume, J. Nesland, G. Kvalheim, K. Beiske, Ø. Fodstad, I. Diel, E. Solomayer, P. Theocharous, R. Coombes, B. Smith, E. Wunder, J. Marolleau, J. Garcia, K. Pantel (1999)
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells.Cytotherapy, 1 5
X. Bessa, J. Elizalde, L. Boix, V. Piñol, A. Lacy, J. Saló, J. Piqué, A. Castells (2001)
Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer.Gastroenterology, 120 5
P. Kufer, A. Zippelius, R. Lutterbüse, I. Mecklenburg, T. Enzmann, A. Montag, D. Weckermann, B. Passlick, N. Prang, P. Reichardt, M. Dugas, M. Köllermann, K. Pantel, G. Riethmüller (2002)
Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.Cancer research, 62 1
Kankatsu Yun, J. Gunn, A. Merrie, L. Phillips, J. McCall (1997)
Keratin 19 mRNA is detectable by RT-PCR in lymph nodes of patients without breast cancer.British Journal of Cancer, 76
M Koch, J Weitz, P Kienle, A Benner, F Willeke, T Lehnert, C Herfarth, M von Knebel Doeberitz (2001)
Comparative analysis of tumor cell dissemination in mesenteric, central, and peripheral blood in patients with colorectal cancer, 136
Stephan Braun, Robert Rosenberg, S. Thorban, N. Harbeck (2001)
Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancer.Seminars in surgical oncology, 20 4
P. Champelovier, F. Mongelard, D. Seigneurin (1999)
CK20 gene expression: technical limits for the detection of circulating tumor cells.Anticancer research, 19 3A
M. Mori, K. Mimori, H. Ueo, K. Tsuji, T. Shiraishi, G. Barnard, K. Sugimachi, T. Akiyoshi (1998)
Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 1
R Rosenberg, A Hoos, J Mueller, H Nekarda (2000)
Cytokeratin‐20 and carcinoembryonic antigen mRNA detection by RT‐PCR in regional lymph nodes: differing prognostic impact in patients with pN0 colorectal carcinoma, 83
T. Bürger, A. Heucke, Z. Halloul, J. Tautenhahn, B. Matthies, U. Schmidt, D. Kunz (2000)
Diagnostik und bedeutung der "minimal residual disease" bei patienten mit kolorektalem karzinomZentralblatt Fur Chirurgie, 125
R. Zigeuner, R. Riesenberg, H. Pohla, A. Hofstetter, R. Oberneder (2000)
Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro.The Journal of urology, 164 5
R. Moll, R. Moll, R. Zimbelmann, Michael Goldschmidt, M. Keith, J. Laufer, M. Kasper, P. Koch, W. Franke (1993)
The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas.Differentiation; research in biological diversity, 53 2
S. Fujita, N. Kudo, T. Akasu, Y. Moriya (2001)
Detection of cytokeratin 19 and 20 mRNA in peripheral and mesenteric blood from colorectal cancer patients and their prognosisInternational Journal of Colorectal Disease, 16
M. Piva, F. Navaglia, D. Basso, P. Fogar, G. Roveroni, N. Gallo, C. Zambon, S. Pedrazzoli, M. Plebani (2000)
CEA mRNA Identification in Peripheral Blood Is Feasible for Colorectal, But Not for Gastric or Pancreatic Cancer StagingOncology, 59
J. Lacroix, M. Doeberitz (2001)
Technical aspects of minimal residual disease detection in carcinoma patients.Seminars in surgical oncology, 20 4
Background The detection of disseminated tumor cells in peripheral blood is limited by the presence of very few tumor cells within a large number of blood cells. Therefore, tumor cell detection calls for enrichment systems with effective depletion of blood cells and high tumor cell recovery. Methods We compared the new density gradient centrifugation method OncoQuick with the standard method of Ficoll. The enriched cell fractions were quantified. Tumor cell spiking experiments examined the recovery of tumor cells as detected by immunocytochemistry and cytokeratin‐20 reverse transcriptase–polymerase chain reaction (RT‐PCR). Clinical application of OncoQuick was evaluated in 37 peripheral blood samples of patients with gastrointestinal carcinomas. Results The depletion of mononuclear cells (MNCs) in the enriched cell fraction after OncoQuick centrifugation was 632‐fold, with an average cell number of 9.5 × 104, compared with Ficoll, with a depletion factor of 3.8 and a mean number of 1.6 × 107 MNCs. The mean tumor cell recovery rates were 87% for OncoQuick and 84% for Ficoll. The increased depletion of MNCs with OncoQuick centrifugation further simplified immunocytochemical evaluation by reducing the number of cytospins and increasing the tumor cell density. Due to the reduced number of co‐enriched MNCs by OncoQuick, the blood volume, which could be analyzed in one RT‐PCR reaction, was increased up to 30 ml. Examination of peripheral blood samples from 37 patients with gastrointestinal tumors showed a cytokeratin‐20 detection rate of 30% and a significant correlation with the presence of distant metastases (P < 0.02). Conclusions OncoQuick significantly reduced the co‐enriched number of MNCs, with a high tumor cell recovery rate. Processing blood from tumor patients with OncoQuick increased the chance of detecting circulating tumor cells. Cytometry 49:150–158, 2002. © 2002 Wiley‐Liss, Inc.
Cytometry Part A – Wiley
Published: Jan 1, 2002
Keywords: ; ; ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.